Lesson 7.3: Respiratory Pathology

Introduction

In this lesson, we will explore respiratory pathology, focusing on obstructive and restrictive lung diseases, pulmonary vascular diseases, and the impact of respiratory infections and lung neoplasia. Our learning objectives include differentiating between obstructive and restrictive diseases by mechanism and testing, as well as explaining the pathogenesis of pulmonary embolism and edema.

Learning Objectives

• Understand obstructive and restrictive lung diseases.
• Explore pulmonary vascular disease, embolism, and edema.
• Examine respiratory infections and lung neoplasia.
• Differentiate obstructive from restrictive disease by mechanism and testing.
• Explain the pathogenesis of pulmonary embolism and edema.

1. Obstructive and Restrictive Lung Diseases

1.1 Overview

Obstructive lung diseases are characterized by a decrease in airflow, which can be caused by conditions that narrow or obstruct the airways. Key examples include Chronic Obstructive Pulmonary Disease (COPD), asthma, and bronchiectasis. In contrast, restrictive lung diseases result from decreased lung expansion, leading to reduced lung volumes. Conditions such as pulmonary fibrosis and obesity hypoventilation syndrome fall under this category.

1.2 Mechanisms

Obstructive Diseases

In obstructive diseases, expiratory airflow is impaired, which can be assessed using spirometry. The primary measurement here is the Forced Expiratory Volume in 1 second (FEV1) to Forced Vital Capacity (FVC) ratio.

• FEV1 is the volume of air exhaled in the first second.
• FVC is the total volume of air exhaled after taking a deep breath.

For obstructive diseases, the FEV1/FVC ratio is typically less than 0.70, indicating airflow limitation.

Restrictive Diseases

In restrictive diseases, both FEV1 and FVC are reduced, but the FEV1/FVC ratio may remain normal or increase (greater than 0.70). This occurs because both measurements decrease proportionally due to lung volume reduction. Conditions such as interstitial lung disease, pneumonia, and neuromuscular disorders hinder lung expansion.

1.3 Example: Spirometry Results

Example Scenario: A patient presents with dyspnea and has a spirometry report showing FEV1 of 1.5 L and FVC of 2.0 L.

• Calculate the FEV1/FVC ratio:

$$ \text{FEV1/FVC} = \frac{1.5 \text{ L}}{2.0 \text{ L}} = 0.75 $$

Since the ratio is above 0.70, this does not indicate an obstructive disease but suggests a possible restrictive disease, warranting further investigation.

1.4 Common Misconceptions

A common misconception is that all lung diseases are either classified strictly as obstructive or restrictive. However, some conditions exhibit mixed patterns, making it essential to interpret clinical data carefully.

2. Pulmonary Vascular Disease, Embolism, and Edema

2.1 Overview of Pulmonary Vascular Disease

Pulmonary vascular disease includes diseases affecting the pulmonary arteries and veins, leading to significant complications such as pulmonary hypertension and embolism. It is crucial to understand how changes in the pulmonary vasculature can affect gas exchange and overall pulmonary function.

2.2 Pulmonary Embolism

Pulmonary embolism (PE) occurs when a clot travels to the pulmonary arteries, obstructing blood flow. The primary causes include venous thromboembolism, often originating from deep vein thrombosis (DVT).

Pathogenesis of Pulmonary Embolism

1. Formation of Thrombus: Clot formation in veins, typically due to stasis, hypercoagulability, or vessel wall injury (Virchow's triad).
2. Dislodgement: The thrombus may detach and travel through the venous system to the right side of the heart.
3. Obstruction of Pulmonary Artery: The clot occludes a pulmonary artery, leading to reduced blood flow, ventilation-perfusion mismatch, and compromised oxygenation.

2.3 Example: Clinical Presentation of PE

Example Scenario: A 60-year-old male presents with sudden onset of shortness of breath, chest pain, and hemoptysis. On examination, he shows tachycardia and decreased oxygen saturation.

• Diagnostic Imaging: A CT pulmonary angiogram is performed, revealing a large embolus in the right pulmonary artery.
• Management: Immediate anticoagulation therapy is initiated to prevent further thrombus propagation.

2.4 Pulmonary Edema

Pulmonary edema involves the accumulation of excess fluid in the lung interstitium and alveoli, impairing gas exchange. Common causes include heart failure, acute respiratory distress syndrome (ARDS), and fluid overload.

Mechanism of Pathogenesis

1. Increased Hydrostatic Pressure: In heart failure, elevated pressures in the pulmonary capillaries lead to fluid leakage into the alveoli.
2. Increased Permeability: Inflammation from ARDS increases capillary permeability, allowing fluid to escape into the interstitial space.
3. Impaired Lymphatic Drainage: Conditions like tumors can obstruct lymphatic vessels, allowing fluid accumulation.

2.5 Example: Identifying Pulmonary Edema

Example Scenario: A patient with history of congestive heart failure presents with severe dyspnea and pink, frothy sputum.

• Chest X-ray Findings: Shows bilateral alveolar infiltrates and kerley B lines.
• Management Approach: Diuretics are administered to reduce fluid overload and improve respiratory function.

Conclusion

Understanding respiratory pathology is critical for assessing and treating various conditions affecting the respiratory system. By mastering the differences between obstructive and restrictive lung diseases, recognizing the mechanisms behind pulmonary vascular diseases such as embolism and edema, and identifying the clinical manifestations of these conditions, students will be better prepared for the complexities of respiratory medicine.

Study Notes

• Distinguish between obstructive (e.g., COPD, asthma) and restrictive (e.g., fibrotic lung diseases) disorders based on spirometry results.
• Identify the pathophysiological mechanisms leading to pulmonary embolism and pulmonary edema.
• Understand the role of venous thrombus formation and factors contributing to pulmonary vascular diseases.
• Recognize clinical signs and understand management strategies for respiratory distress syndromes.